EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS

EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS

Since 2011, with the emergence of new classes of antithrombotic drugs – inhibitors of the activated X coagulation factor (rivoroxaban, apixaban, edoxaban) and thrombin inhibitor (dabigatran), antithrombotic therapy has received a new impetus to development and wider introduction into practice. New o...

Full description

Bibliographic Details
Main Authors: T. V. Voskresenskaya, A. G. Azizova, S. A. Zubritskaya, S. V. Kuleshova, L. O. Minushkina
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-11-01
Series:Медицинский совет
Subjects:
atrial fibrillation
anticoagulant
Online Access:https://www.med-sovet.pro/jour/article/view/2023

Similar Items

Similar Items